Kaufman, J., Kastritis, E., Joseph, N., Gavriatopoulou, M., Gu, L., Hofmeister, C., Gupta, V., Terpos, E., Nooka, A., Lonial, S., Dimopoulos, M. (2025). Characterization of NDMM patients treated with daratumumab, lenalidomide, bortezomib and dexamethasone who fail to achieve a VGPR or have early progression. Blood. https://doi.org/10.1182/blood-2025-407